INCR - Intercure Ltd.
IEX Last Trade
1.66
0.010 0.602%
Share volume: 0
Last Updated: Thu 26 Dec 2024 04:25:24 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.82%
PREVIOUS CLOSE
CHG
CHG%
$1.65
0.01
0.61%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
14.09%
1 Month
19.72%
3 Months
-9.09%
6 Months
-22.02%
1 Year
26.87%
2 Year
-50.58%
Key data
Stock price
$1.66
DAY RANGE
N/A - N/A
52 WEEK RANGE
$1.24 - $3.71
52 WEEK CHANGE
$36.00
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Alexander Rabinovitch
Region: US
Website: intercure.co
Employees: 350
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: intercure.co
Employees: 350
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
InterCure Ltd. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector.
Recent news